Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 8, 2019 Off

Genprex Retains Addison Whitney for Drug Nomenclature Branding

By BusinessWire

Genprex takes next steps toward identifying drug name for future commercialization AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX),…

May 8, 2019 Off

A&E to Preview ‘Integrity’ Molecular-Tagged Thread Solution From Applied DNA Sciences at Texprocess

By BusinessWire

STONY BROOK, N.Y.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24apdn&src=ctag" target="_blank"gt;$apdnlt;/agt; lt;a href="https://twitter.com/hashtag/anticounterfeiting?src=hash" target="_blank"gt;#anticounterfeitinglt;/agt;–Applied DNA Sciences, Inc. (NASDAQ:APDN), announced today that American & Efird (A&E),…

May 8, 2019 Off

Millendo Therapeutics Announces 21st European Congress of Endocrinology 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia

By BusinessWire

ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced…

May 8, 2019 Off

Neuropore Initiates Phase 1 Clinical Trial in Healthy Volunteers with NPT520-34, a Therapeutic Candidate Aimed at Treating Parkinson’s Disease and Amyotrophic Lateral Sclerosis

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ALS?src=hash" target="_blank"gt;#ALSlt;/agt;–Neuropore Therapies, Inc. announced today that it has initiated a Phase 1 clinical trial in healthy…

May 8, 2019 Off

Adimab Announces Antibody Discovery Platform Transfer with Takeda

By BusinessWire

Sixth pharma partner to internalize the Adimab platform LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the global leader in the discovery and optimization…

May 8, 2019 Off

Adimab Expands Research Agreement with Regeneron

By BusinessWire

LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the leading provider of antibody discovery and optimization technology, today announced the expansion of an earlier…

May 8, 2019 Off

Adimab Announces Multi-Target Expansion for the Discovery of Antibodies with Another Global Pharma Partner

By BusinessWire

LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced…

May 8, 2019 Off

CEL-SCI Corporation Releases Letter to Shareholders

By BusinessWire

VIENNA, Va.–(BUSINESS WIRE)–The following letter was sent by CEL-SCI Corporation (NYSE American: CVM) to its shareholders: Dear CEL-SCI Shareholders: The…

May 8, 2019 Off

IVERIC bio Reports First Quarter 2019 Financial and Operating Results

By BusinessWire

– Conference Call and Webcast Today, May 8, 2019, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)–IVERIC bio (Nasdaq: ISEE)…

May 8, 2019 Off

Horizon Therapeutics plc Reports Strong First-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance

By BusinessWire

— First-Quarter 2019 Net Sales of $280.4 Million Increased 25 Percent; First-Quarter 2019 GAAP Net Loss of $32.9 Million; Adjusted…

Posts pagination

Previous 1 … 3,214 3,215 3,216 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine